You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR NORDITROPIN NORDIFLEX


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NORDITROPIN NORDIFLEX

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00936403 ↗ A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone Completed Novo Nordisk A/S Phase 2 2009-08-01 This trial is conducted in Europe. The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetics (the determination of the concentration of the administered medication in blood over time) and pharmacodynamics (the determination of the effect over time and the duration of action) of a long-acting growth hormone (NNC126-0083) in growth hormone deficient children.
NCT01327924 ↗ Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone Completed Novo Nordisk A/S 2011-04-01 This study is conducted in Europe. The purpose of this study is to assess the impact on daily life for children new to using a growth hormone injection device.
NCT01706783 ↗ A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency Completed Novo Nordisk A/S Phase 1 2012-10-12 This trial is conducted in Europe. The aim of the trial is to investigate the safety, tolerability, availability and distribution in the body of once-weekly long-acting growth hormone (NNC0195-0092, somapacitan) compared to once daily Norditropin NordiFlex® in adults with growth hormone deficiency (GHD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NORDITROPIN NORDIFLEX

Condition Name

Condition Name for NORDITROPIN NORDIFLEX
Intervention Trials
Growth Hormone Disorder 3
Growth Hormone Deficiency in Children 2
Chronic Renal Insufficiency 1
Delivery Systems 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NORDITROPIN NORDIFLEX
Intervention Trials
Dwarfism, Pituitary 3
Gonadal Dysgenesis 1
Endocrine System Diseases 1
Genetic Diseases, Inborn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NORDITROPIN NORDIFLEX

Trials by Country

Trials by Country for NORDITROPIN NORDIFLEX
Location Trials
France 2
Denmark 2
Macedonia, The Former Yugoslav Republic of 1
Turkey 1
Czech Republic 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NORDITROPIN NORDIFLEX

Clinical Trial Phase

Clinical Trial Phase for NORDITROPIN NORDIFLEX
Clinical Trial Phase Trials
Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NORDITROPIN NORDIFLEX
Clinical Trial Phase Trials
Completed 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NORDITROPIN NORDIFLEX

Sponsor Name

Sponsor Name for NORDITROPIN NORDIFLEX
Sponsor Trials
Novo Nordisk A/S 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NORDITROPIN NORDIFLEX
Sponsor Trials
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.